Company profile
Wesana Health Holdings Inc.
OTC: WSNAF · Healthcare · Biotechnology
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 21
v0.1 · 5/100 weight · pillars only
↑ disclosure history, balance-sheet leverage · ↓ 3-yr revenue growth, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.8M
Employees
7
as of 2026-08-27
Market cap
$73.2k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02023
Net income-$1.8M-$1.8M2023
Operating income-$1.1M-$1.1M2023
Total assets$993.0k$993.0k2023
Liabilities$1.3M$1.3M2023
Equity-$272.6k-$272.6k2023
Revenue trend
FY2014 – FY2023 · USD
FY14
FY15
FY18
FY19
FY20
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Wesana Health Holdings Inc.’s revenue?
Wesana Health Holdings Inc. booked $0 in FY2023 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
ProtoKinetix, Incorporated——Digicann Ventures Inc.16DWellstar International, Inc.——Pathfinder Cell Therapy, Inc.——PaxMedica, Inc. Common Stock——Biome Grow Inc.——Neighbors
Cook →Key facts
CEODaniel Carcillo
SectorHealthcare
IndustryBiotechnology
HeadquartersChicago, IL
ExchangeOTC: WSNAF
Employees7
IPO date2021-06-04
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.